跳至主要内容
临床试验/NCT03762694
NCT03762694已完成不适用

The Effect of Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy: A Randomized, Wait-list Controlled Pilot Study

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年3月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Change in Insomnia Severity Index (ISI)

研究概览

简要总结

This pilot study is designed to determine whether acupuncture is a feasible, effective and safe method for alleviating insomnia among breast cancer patients undergoing chemotherapy as compared with a wait-list control.

详细描述

Hypothesis:

Acupuncture is a feasible, effective and safe method for alleviation of insomnia symptoms in breast cancer patients undergoing chemotherapy as compared with a wait-list control.

Objective:

To determine whether the insomnia condition in the acupuncture group is significantly improved when compared to the wait-list control group.

Design and strategy:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients between 18 and 75 years of age;
  • Diagnosis of stage (American Joint Committee on Cancer (AJCC) TNM) I-IV breast cancer;
  • Currently receiving chemotherapy, or have completed chemotherapy no more than 6 months;
  • Insomnia onset after the diagnosis of breast cancer;
  • Insomnia occurs at least 3 nights per week, and presents for at least 1 month, with fulfilment of the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnostic criteria for brief insomnia disorder;
  • Insomnia severity as defined by an ISI score of no less than 10 in the past 2 weeks;
  • Expected survival time of more than 6 months;
  • Ability to understand the nature of the study and willingness to give informed consent;
  • Ability to provide responses during outcome measurement.

排除标准

  • Insomnia before the diagnosis of breast cancer;
  • Other sleep disorder (e.g., obstructive sleep apnoea);
  • Shift work or irregular sleep pattern;
  • Severe visual, hearing or language defects;
  • Severe hematological dysfunction (platelet count <60,000/μL, haemoglobin <8 g/dL or absolute neutrophil count <1000/μL);
  • With pacemakers or other electronic implants that could interfere with electroacupuncture;
  • History of acupuncture use in the previous 3 months;
  • Participation in other clinical trials with intervention within 3 months of the beginning of the trial.

结局指标

主要结局

Change in Insomnia Severity Index (ISI)

时间窗: week 0, 3, 6 (primary outcome), 10, 14

次要结局

  • Actigraphy(week 0, 6)
  • Pittsburgh Sleep Quality Index(week 0, 3, 6, 10, 14)
  • Adverse events(week 0 to week 6)
  • Sleep diary(week 0, 6)
  • Functional Assessment of Cancer Therapy-Breast Cancer(week 0, 6, 10, 14)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor LAO Lixing

Professor

The University of Hong Kong

研究点 (1)

Loading locations...

相似试验